Houlihan Lokey Advises Shore Capital Partners
Houlihan Lokey is pleased to announce that Shore Capital Partners (Shore) has made a strategic investment in support of the recapitalization and growth of Point C. The transaction closed in November 2024.
Point C is a third-party administrator of medical benefits, cost containment, and other administrative services for self-funded employers. The company was formed through its initial partnership with Benefit Plan Administrators and grew to become a leading company in the TPA industry through a combination of organic growth, acquisition, and investment. Shore believes its investment will allow Point C to capitalize on a robust pipeline of acquisition opportunities, pursue additional cost containment solutions, and take advantage of sector growth with rising healthcare costs driving self-funding and TPA tailwinds.
Shore, a Chicago-based private equity firm with offices in Nashville, is an investor in lower-middle-market companies in the healthcare, food and beverage, business services, industrial, and real estate industries. Shore’s strategy is to support management partners to grow faster with less risk through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 2020 to 2024, Shore received recognition from Inc. Magazine as a five-time “Founder-Friendly Investor” and by PitchBook Research for being the global leader in private equity total deal volume from 2019 to 2023. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has $9.1 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. The fund will invest in a combination of external companies and currently held microcap portfolio companies while maintaining a sector-driven and operationally focused approach. The Advantage Fund was announced in October 2024, exceeding Shore’s fundraising target, and Point C is the first investment by the fund.
Houlihan Lokey served as the exclusive financial advisor to Shore on the transaction. This transaction underlines the Healthcare Group’s leadership position in employer-sponsored healthcare, as well as the expertise of Houlihan Lokey’s Fund Opinions practice.
Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2023, the group closed 34 transactions and was ranked by LSEG (formerly Refinitiv) as the No. 1 investment bank for all global healthcare M&A transactions.
RELATED: Healthcare, Corporate Finance, Financial and Valuation Advisory